Significant Ownership of KINGDON CAPITAL MANAGEMENT, L.L.C.

Signature - Title
By: /s/ Richard Weinstein - Richard Weinstein / Chief Operating Officer & General Counsel
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by KINGDON CAPITAL MANAGEMENT, L.L.C..

Notify me when KINGDON CAPITAL MANAGEMENT, L.L.C. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of KINGDON CAPITAL MANAGEMENT, L.L.C.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NVNO enVVeno Medical Corporation Common Stock, $0.00001 par value 7.1% $5,804,044 1,359,261 Kingdon Capital Management, L.L.C. 02 Sep 2025
SCYX SCYNEXIS INC Common Stock, par value $0.001 per share 5.3% $1,722,527 2,237,048 Kingdon Capital Management, L.L.C. 30 Sep 2025
OPTN OptiNose, Inc. Common Stock, $0.001 par value per share 5.1% $4,736,414 520,485 KINGDON CAPITAL MANAGEMENT, L.L.C. 09 Apr 2025
JSPR Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 4.7% $3,153,131 +$1,332,431 1,324,845 +73% Kingdon Capital Management, L.L.C. 30 Sep 2025

Schedules 13D/G Reported by KINGDON CAPITAL MANAGEMENT, L.L.C.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.